questionText: To ask the Secretary of State for Health and Social Care, what formal mechanisms are in place to ensure that the views of patients, families and brain cancer patient advocacy organisations are reflected in the work of the National Clinical Lead for Rare Cancers, the Rare Cancer Speciality Lead and the National Cancer Board; and how those bodies will be expected to respond to, and report on, the concerns raised through those mechanisms.